Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 26, Issue 23, pp. 6086-6101
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 16, 2020
- Revision received June 27, 2020
- Accepted July 22, 2020
- Published first July 24, 2020.
Article Versions
- Previous version (July 24, 2020 - 06:30).
- Previous version (November 6, 2020 - 05:52).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Pilar Navarro1,2,3,##,*,
- Neus Martínez-Bosch2,#,
- Ada G. Blidner4,#, and
- Gabriel A. Rabinovich4,5,##,*
- 1Institute of Biomedical Research of Barcelona (IIBB-CSIC), Barcelona, Spain.
- 2Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Unidad Asociada IIBB-CSIC, Barcelona, Spain.
- 3Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
- 4Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental, Ciudad de Buenos Aires, Argentina.
- 5Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad de Buenos Aires, Argentina.
- ↵*Corresponding Authors:
Gabriel A. Rabinovich, IBYME-CONICET/University of Buenos Aires, Vuelta de Obligado 2490, Ciudad de Buenos Aires 1428, Argentina. Phone: 5411-4783-2869, ext. 269; Fax: 5411-4786-2564; E-mail: gabyrabi{at}gmail.com; and Pilar Navarro, Institute of Biomedical Research of Barcelona (IIBB-CSIC), C/Rossellón 161, 6ª planta, Barcelona 08036, Spain. E-mail: pilar.navarro{at}iibb.csic.es
December 2020
Volume 26, Issue 23
Volume 26, Issue 23
Impact of Galectins in Resistance to Anticancer Therapies
Jump to section
Advertisement